menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Cholestero...
source image

Bioengineer

4d

read

73

img
dot

Image Credit: Bioengineer

Cholesterol Fuels Colorectal Cancer: Gut Microbiota and Simvastatin Counteract

  • Recent research highlights the crucial role of cholesterol in colorectal cancer (CRC) progression and unveils interventions to counteract it, as discussed in a study published in BMC Cancer.
  • Elevated serum cholesterol levels have been linked to colorectal tumor growth, with LDL cholesterol impacting tumorigenesis, as evidenced in advanced mouse models.
  • The study shows that hypercholesterolemia accelerates colorectal tumor growth, leading to larger tumors with increased cellular proliferation and aggressiveness.
  • Therapeutic interventions involving Lactobacillus supplementation and Simvastatin treatment mitigate tumor growth and improve immune response by modulating gut microbiota and cholesterol levels.
  • Lactobacillus administration alters gut microbiota composition, enriching beneficial bacterial taxa that may exert anti-inflammatory and antineoplastic effects in the colorectal environment.
  • Simvastatin treatment reduces serum LDL levels, suppresses PD-L1 expression on cancer cells, and enhances cytotoxic T cell infiltration into tumor tissues.
  • The dual approach of probiotic supplementation and pharmacological intervention presents a promising strategy to suppress tumor growth and enhance immune-mediated tumor clearance in CRC management.
  • Cholesterol's role in cancer progression lies in facilitating tumor cell proliferation and malignancy through its influence on signaling pathways regulating growth and survival.
  • The study underscores the value of preclinical modeling in understanding the complex interactions between metabolism and cancer, providing insights for integrated cancer treatment strategies.
  • The findings suggest the potential repurposing of cholesterol-lowering drugs like statins, such as Simvastatin, as adjuncts to immunotherapy to overcome resistance mechanisms in colorectal cancer.

Read Full Article

like

4 Likes

For uninterrupted reading, download the app